Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1107 of 1,261
  1. US 7078412

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall Prodesfarma S.A. Β· Granted Jul 18, 2006 Β· Expires Jul 13, 2026

    granted
  2. US 2006153775

    Compounds for targeting endothelial cells, compositions containing the same and methods for their use

    BRACCO INT BV [NL] Β· Granted Jul 13, 2006 Β· Expires Jul 8, 2026

    granted
  3. US 7074893

    Methods and compositions for the treatment of diseases associated with signal transduction aberrations

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  4. US 7074410

    Modified HCV peptide vaccines

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  5. US 7074765

    Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  6. US 7074782

    Carbamate caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  7. US 7074760

    Polyacid glycopeptide derivatives

    Theravance, Inc. Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  8. US 7074554

    Antibodies specific for NEBR1 and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  9. US 7073512

    Adhesion prevention and an endoscopic insufflation system therefor

    Saturnus AG Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  10. US 7074761

    Peptides and production and use thereof

    Takeda Chemical Ind., Ltd. Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  11. US 7074900

    Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin

    The Regents of the University of California Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  12. US 7074890

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  13. US 7074924

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  14. US 7074938

    Method for the synthesis of soritin compounds

    The Regents of the University of California Β· Granted Jul 11, 2006 Β· Expires Jul 6, 2026

    granted
  15. AU 2001289696

    New use of lipase inhibitors

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] Β· Granted Jul 6, 2006 Β· Expires Jul 1, 2026

    granted
  16. US 7071293

    Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt

    The Regents of the University of California Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  17. US 7070607

    Bioabsorbable polymeric implants and a method of using the same to create occlusions

    The Regents of the University of California Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  18. US 7070771

    Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells

    The Regents of the University of California Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  19. US 7070790

    Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  20. US 7070971

    Glycosyl sulfotransferases GST-4Ξ±, GST-4Ξ², and GST-6

    The Regents of the University of California Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  21. US 7070788

    Follicle stimulating hormone superagonists

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  22. US 7070959

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  23. US 7070805

    Rapidly disintegrable solid preparation

    Takeda Pharmaceutical Company Limited Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted
  24. US 7070957

    STARSβ€”a muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System Β· Granted Jul 4, 2006 Β· Expires Jun 29, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.